Helen Alexandra Shaw (Helen A Shaw)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 4

Top Topics

Genetic Diversity

Clostridium Difficile

Cystic Fibrosis

Top Venues

Scientific reports

This page only lists publications with an associated author ORCID identifier.

Publications

Keira Burns, Helge C Dorfmueller, Brendan W Wren, Fatme Mawas, Helen Alexandra Shaw
Progress towards a glycoconjugate vaccine against Group A Streptococcus. NPJ vaccines 8 (1) (2023)
Helen Alexandra Shaw, Alex Remmington, Giselle McKenzie, Caroline Winkel, Fatme Mawas
Mucosal Immunization Has Benefits over Traditional Subcutaneous Immunization with Group A Streptococcus Antigens in a Pilot Study in a Mouse Model. Vaccines 11 (11) (2023)
Keira Burns, Helge C Dorfmueller, Brendan W Wren, Fatme Mawas, Helen Alexandra Shaw
Progress towards a glycoconjugate vaccine against Group A Streptococcus. NPJ vaccines 8 (1) (2023)
Helen Alexandra Shaw, Ladan Khodadoost, Mark D Preston, Jeroen Corver, Peter Mullany, Brendan W Wren
Clostridium difficile clade 3 (RT023) have a modified cell surface and contain a large transposable island with novel cargo. Scientific reports 9 (1) (2019)